Aspire Biopharma Stock (NASDAQ:ASBP)


OwnershipFinancialsChart

Previous Close

$0.38

52W Range

$0.21 - $15.80

50D Avg

$0.41

200D Avg

$7.21

Market Cap

$18.10M

Avg Vol (3M)

$12.33M

Beta

0.91

Div Yield

-

ASBP Company Profile


Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Apr 11, 2022

Website

ASBP Performance


ASBP Financial Summary


Dec 23Dec 22
Revenue--
Operating Income$-358.59K$-596.49K
Net Income$-359.07K$-597.12K
EBITDA$-358.59K$-596.49K
Basic EPS$-0.01$-0.01
Diluted EPS$-0.01$-0.01

Fiscal year ends in Dec 23 | Currency in USD